|
1
|
Minagawa S, Hanyu O and Sone H: Stroke in
the elderly people with diabetes mellitus. Nihon Rinsho.
71:1948–1953. 2013.(In Japanese).
|
|
2
|
Palazzo P, Maggio P, Altavilla R, et al:
Cerebral hemodynamics and systemic endothelial function are already
impaired in well-controlled type 2 diabetic patients, with
short-term disease. PLoS One. 8:e832872013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mao X, Wang T, Liu Y, et al:
N-acetylcysteine and allopurinol confer synergy in attenuating
myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in
diabetic rats. PLoS One. 8:e689492013.PubMed/NCBI
|
|
4
|
Ayala de la Peña F, Kanasaki K, Kanasaki
M, et al: Loss of p53 and acquisition of angiogenic microRNA
profile are insufficient to facilitate progression of bladder
urothelial carcinoma in situ to invasive carcinoma. J Biol Chem.
286:20778–20787. 2011.PubMed/NCBI
|
|
5
|
Luo F and Hu TH: Overexpression of miR-18a
suppresses tumor angiogenesis in colon cancer. Zhonghua Xian Dai Yi
Xue Za Zhi. 23:37–41. 2013.(In Chinese).
|
|
6
|
No authors listed. Report of the expert
committee on the diagnosis and classification of diabetes mellitus.
Diabetes Care. 20:1183–1197. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chromy BA, Eldridge A, Forsberg JA, et al:
Wound outcome in combat injuries is associated with a unique set of
protein biomarkers. J Transl Med. 11:2812013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siddiqi SS, Gupta R, Aslam M, Hasan SA and
Khan SA: Type-2 diabetes mellitus and auditory brainstem response.
Indian J Endocrinol Metab. 17:1073–1077. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Foerch C, Singer OC, Neumann-Haefelin T,
et al: Evaluation of serum S100B as a surrogate marker for
long-term outcome and infarct volume in acute middle cerebral
artery infarction. Arch Neurol. 62:1130–1134. 2005.PubMed/NCBI
|
|
10
|
Wang SZ, Ma CC, Cao LL, Wei RY and Chi ZF:
Detection and significance of serum neuron-specific enolase in
elderly stroke patients. Zhongguo Lao Nian Xue Za Zhi. 26:410–411.
2006.(In Chinese).
|
|
11
|
Wunderlich MT, Wallesch CW and Goertler M:
Release of neurobiochemical markers of brain damage is related to
the neurovascular status on admission and the site of arterial
occlusion in acute ischemic stroke. J Neurol Sci. 227:49–53. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yanagisawa M, Kurihara H, Kimura S, Goto K
and Masaki T: A novel peptide vasoconstrictor, endothelin, is
produced by vascular endothelium and modulates smooth muscle
Ca2+ channels. J Hypertens Suppl. 6:S188–S191. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morfoisse F, Kuchnio A, Frainay C, et al:
Hypoxia induces VEGF-C expression in metastatic tumor cells via a
HIF-1α-independent translation-mediated mechanism. Cell Rep.
6:155–167. 2014.PubMed/NCBI
|
|
14
|
Grebhardt S, Veltkamp C, Ströbel P and
Mayer D: Hypoxia and HIF-1 increase S100A8 and S100A9 expression in
prostate cancer. Int J Cancer. 131:2785–2794. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang J, Qian Y, Xu D, et al: Serum tumor
markers, hypoxia-inducible factor-1α HIF-1α and vascular
endothelial growth factor, in patients with non-small cell lung
cancer before and after intervention. Asian Pac J Cancer Prev.
14:3851–3854. 2013.
|
|
16
|
Revet I, Feeney L, Tang AA, et al:
Dysmyelination not demyelination causes neurological symptoms in
preweaned mice in a murine model of Cockayne syndrome. Proc Natl
Acad Sci USA. 109:4627–4632. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sagar SK, Zhang C, Guo Q, et al: Role of
expression of endothelin-1 and angiotensin-II and hypoxia-inducible
factor-1α in the kidney tissues of patients with diabetic
nephropathy. Saudi J Kidney Dis Transpl. 24:959–964. 2013.
|
|
18
|
Bertozzi D, Marinello J, Manzo SG, et al:
The natural inhibitor of DNA topoisomerase I, camptothecin,
modulates HIF-1α activity by changing miR expression patterns in
human cancer cells. Mol Cancer Ther. 13:239–248. 2014.PubMed/NCBI
|
|
19
|
Chai ZT, Kong J, Zhu XD, et al:
MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through
the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma. PLoS
One. 8:e779572013.PubMed/NCBI
|
|
20
|
Lemaire J, Mkannez G, Guerfali FZ, et al:
MicroRNA expression profile in human macrophages in response to
Leishmania major infection. PLoS Negl Trop Dis. 7:e24782013.
View Article : Google Scholar : PubMed/NCBI
|
